{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:45:03Z","timestamp":1784195103153,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.anaerobe.2019.102146","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:27:25Z","timestamp":1577446045000},"page":"102146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["In\u00a0vitro and in\u00a0vivo anti-clostridial activity of newly isolated Pediococcus acidilactici SPM138 against Clostridium difficile"],"prefix":"10.1016","volume":"61","author":[{"given":"Min Kyoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SungSook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2019.102146_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MOG.0000000000000018","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"30","author":"Honda","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","article-title":"Narrative review: the new epidemic of Clostridium difficile-associated enteric disease","volume":"145","author":"Bartlet","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09674845.2008.11732796","article-title":"Clostridium difficile: from obscurity to superbug","volume":"65","author":"Brazier","year":"2008","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.anaerobe.2019.102146_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1099\/jmm.0.05376-0","article-title":"Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization","volume":"53","author":"Ozaki","year":"2004","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib5","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/archinte.162.19.2177","article-title":"The spectrum of pseudomembranous enterocolitis and antibiotic associated diarrhea","volume":"162","author":"Hurley","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib6","first-page":"850","article-title":"Recent advances in Clostridium difficile-associated disease","volume":"57","author":"Monaghan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.anaerobe.2019.102146_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice; Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJM199911253412211","article-title":"Antibiotics and Clostridium difficile","volume":"341","author":"Gorbach","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMe1214816","article-title":"Fecal microbiota transplantation \u2013an old therapy comes of age","volume":"368","author":"Kelly","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1475-2859-12-71","article-title":"Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease","volume":"12","author":"Mart\u00edn","year":"2013","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.anaerobe.2019.102146_bib11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am. J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.anaerobe.2019.102146_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2180-14-177","article-title":"Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells","volume":"2","author":"Boonma","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anaerobe.2018.12.004","article-title":"Evaluation of protective effect of Lactobacillus acidophilus La-5 on toxicity and colonization of Clostridium difficile in human epithelial cells in\u00a0vitro","volume":"55","author":"Najarian","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2019.102146_bib14","first-page":"17","article-title":"Lactic acid bacteria as live vaccines","volume":"2","author":"Mercenier","year":"2000","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib15","first-page":"4607491","article-title":"Probiotic Lactobacillus strains stimulate the inflammatory response and activate human macrophages","author":"Rocha-Ram\u00edrez","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.anaerobe.2019.102146_bib16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1017\/S000711451100287X","article-title":"Health benefits and health claims of probiotics: bridging science and marketing","volume":"106","author":"Rijkers","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.anaerobe.2019.102146_bib17","first-page":"577","article-title":"Screening of Bifidobacteria and Lactobacilli able to antagonize the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer","volume":"22","author":"Vald\u00e9s-Varela","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anaerobe.2018.12.004","article-title":"Evaluation of protective effect of Lactobacillus acidophilus La-5 on toxicity and colonization of Clostridium difficile in human epithelial cells in\u00a0vitro","volume":"55","author":"Najarian","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2019.102146_bib19","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3389\/fmicb.2018.02396","article-title":"Protective effect of Pediococcus pentosaceus LI05 against Clostridium difficile infection in a mouse model","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib20","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: 19th Informational Supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.anaerobe.2019.102146_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/1574-6968.12367","article-title":"Small animal models for the study of Clostridium difficile disease pathogenesis","volume":"352","author":"Hutton","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"issue":"2008","key":"10.1016\/j.anaerobe.2019.102146_bib22","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile-more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jiac.2018.08.003","article-title":"Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: meta-analysis of randomized controlled trials","volume":"24","author":"Igarashi","year":"2018","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.anaerobe.2019.102146_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5009\/gnl18071","article-title":"Recurrent Clostridium difficile infection: risk factors, treatment, and prevention","volume":"15","author":"Song","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.anaerobe.2019.102146_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomized controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.102146_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gut.49.1.152","article-title":"Recurrent Clostridium difficile diarrhoea","volume":"49","author":"Kyne","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.anaerobe.2019.102146_bib28","first-page":"224","article-title":"Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG","volume":"21","author":"Biller","year":"1995","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.anaerobe.2019.102146_bib29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1345\/aph.1K110","article-title":"Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii","volume":"41","author":"Segarra-Newnham","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.anaerobe.2019.102146_bib30","first-page":"e56","article-title":"Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis","volume":"7","author":"Pattani","year":"2013","journal-title":"Open Med."},{"key":"10.1016\/j.anaerobe.2019.102146_bib31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/cid\/cit147","article-title":"Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection","volume":"56","author":"El Feghaly","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.102146_bib32","first-page":"24","article-title":"Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity","volume":"4","author":"Yu","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijfoodmicro.2009.05.005","article-title":"In\u00a0vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes","volume":"133","author":"Dabour","year":"2009","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s12010-013-0585-4","article-title":"Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL\/6 mice models","volume":"172","author":"Kaur","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.anaerobe.2019.102146_bib35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/gast.2002.32386","article-title":"Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation","volume":"122","author":"He","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anaerobe.2019.102146_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0016-5085(98)70196-9","article-title":"Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease","volume":"115","author":"Singer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anaerobe.2019.102146_bib37","first-page":"1170","article-title":"Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease","volume":"92","author":"Hendel","year":"1997","journal-title":"Am. J. Gastroenterol."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419302185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419302185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:38:54Z","timestamp":1761035934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996419302185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":37,"alternative-id":["S1075996419302185"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102146","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro and in\u00a0vivo anti-clostridial activity of newly isolated Pediococcus acidilactici SPM138 against Clostridium difficile","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102146"}}